文献速递间质性肺疾病

肺活检在纤维化性间质性肺病中的临床价值

Clinical utility of lung biopsy in fibrotic interstitial lung disease.
PubMed 文献 · Am J Respir Crit Care Med · 2026-01-01

该多学科专家与患者代表共同撰写的前沿文件,系统总结了纤维化性间质性肺病(fILD)评估中支持与反对肺活检的理由。文章涵盖经支气管活检、经支气管肺冷冻活检及电视辅助胸腔镜手术肺活检等多种方式,强调活检决策需权衡诊断信心提升与操作风险,并考虑患者价值观与偏好。未来研究应优先开发与验证可替代或辅助活检的微创及无创手段。

要点

  • 肺活检在fILD诊断不确定时仍具重要作用,但最佳时机与方式选择存在明显模糊性。
  • 活检决策需综合诊断信心提升、治疗决策需求、操作风险及患者偏好进行个体化权衡。
  • 未来应优先研发和验证可替代或辅助活检的微创与无创诊断技术。

核心结论

  • 肺活检在fILD评估中的价值是多方面的,需在诊断获益与操作风险之间个体化权衡。
  • 未来研究应优先开发与验证可替代或辅助活检的微创及无创诊断手段。

研究设计与样本

  • 本文为多学科专家与患者代表共同撰写的前沿文件,总结fILD中支持与反对肺活检的理由。

主要发现

  • fILD可用的肺活检方式包括经支气管活检、经支气管肺冷冻活检及几乎均以微创电视辅助胸腔镜手术进行的 Surgical lung biopsy。
  • 支持肺活检的理由包括提高诊断信心和指导治疗决策,需与操作风险及患者价值观和偏好共同权衡。
  • 关于肺活检的最佳时机和方式选择存在大量模糊性。

临床怎么用

  • 临床决策时应综合评估诊断不确定性、拟行活检方式的风险及患者偏好,个体化决定是否及何时进行肺活检。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lung biopsy has traditionally played a fundamental role in addressing diagnostic uncertainty and guiding management of fibrotic interstitial lung disease (fILD). Multiple lung biopsy procedures are available for evaluating fILD, including bronchoscopic techniques such as transbronchial biopsy and transbronchial lung cryobiopsy, as well as surgical lung biopsy, which is now almost exclusively conducted using minimally invasive video-assisted thoracoscopic surgery. The various evolving -considerations for and against lung biopsy have led to substantial ambiguity regarding the optimal timing and choice of biopsy method. The rationale for performing a lung biopsy in fILD is multifaceted, shaped by its potential to enhance diagnostic confidence and inform therapeutic decisions, weighed against procedural risks, and further nuanced by patient values and preferences. The objective of this state-of-the-art document from a multidisciplinary group of experts and patient representatives is to summarize the rationale for and against lung biopsy in the evaluation and management of fILD. Amid ongoing technological innovations, we further emphasize that future research should prioritize the development and validation of minimally invasive and noninvasive modalities that may serve as either alternatives or adjuncts to biopsy in the diagnostic evaluation of fILD.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Mor E, Piciucchi S, Ravaglia C, et al. Clinical utility of lung biopsy in fibrotic interstitial lung disease. Am J Respir Crit Care Med. 2026. PMID: 41738223. doi:10.1093/ajrccm/aamaf123

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。